{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:36:42Z","timestamp":1790818602672,"version":"4.1.0"},"reference-count":41,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T00:00:00Z","timestamp":1489449600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T00:00:00Z","timestamp":1489449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"funder":[{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"name":"M.D. Anderson Cancer Center High Risk Multiple Myeloma Moon Shot"},{"name":"Stading-Younger Cancer Research Foundation"},{"name":"M.D. Anderson Molecular Evaluation and\/or Biopsy Related Support Program"},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50 CA142509"],"award-info":[{"award-number":["P50 CA142509"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA184464"],"award-info":[{"award-number":["R01 CA184464"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA194264"],"award-info":[{"award-number":["CA194264"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U10 CA032102"],"award-info":[{"award-number":["U10 CA032102"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1111\/bjh.14570","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T21:13:28Z","timestamp":1489526008000},"page":"457-466","source":"Crossref","is-referenced-by-count":202,"title":["Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma"],"prefix":"10.1111","volume":"177","author":[{"given":"Nina","family":"Shah","sequence":"first","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy; University of Texas M.D. Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy; University of Texas M.D. Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"McCarty","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy; University of Texas M.D. Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indreshpal","family":"Kaur","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy; University of Texas M.D. Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Yvon","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy; University of Texas M.D. Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hila","family":"Shaim","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy; University of Texas M.D. Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muharrem","family":"Muftuoglu","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy; University of Texas M.D. Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enli","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy; University of Texas M.D. Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Z.","family":"Orlowski","sequence":"additional","affiliation":[{"name":"Department of Lymphoma\/Myeloma; University of Texas M.D. Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; University of Texas M.D. Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Hematology & Oncology; Nationwide Children's Hospital; Columbus OH USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simrit","family":"Parmar","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy; University of Texas M.D. Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine; University of Texas M.D. Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Sobieiski","sequence":"additional","affiliation":[{"name":"Institute of Human Nutrition; Columbia University; College of Physicians and Surgeons; New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"Saliba","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy; University of Texas M.D. Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0409-5556","authenticated-orcid":false,"given":"Chitra","family":"Hosing","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy; University of Texas M.D. Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sairah","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy; University of Texas M.D. Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yago","family":"Nieto","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy; University of Texas M.D. Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qaiser","family":"Bashir","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy; University of Texas M.D. Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krina","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy; University of Texas M.D. Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Bollard","sequence":"additional","affiliation":[{"name":"Departments of Allergy and Immunology and Blood and Marrow Transplantation; Children's National Health System and George Washington University; Washington DC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzaffar","family":"Qazilbash","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy; University of Texas M.D. Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Champlin","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy; University of Texas M.D. Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Rezvani","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy; University of Texas M.D. Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Shpall","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation and Cellular Therapy; University of Texas M.D. Anderson Cancer Center; Houston TX USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,3,14]]},"reference":[{"key":"10.1111\/bjh.14570-BIB0001|bjh14570-cit-0001","doi-asserted-by":"publisher","first-page":"265840","DOI":"10.1155\/2014\/265840","article-title":"Lenalidomide induces immunomodulation in chronic lymphocytic leukemia and enhances antitumor immune responses mediated by NK and CD4 T cells","volume":"2014","author":"Acebes-Huerta","year":"2014","journal-title":"Biomed Research International"},{"key":"10.1111\/bjh.14570-BIB0002|bjh14570-cit-0002","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/bmt.2013.189","article-title":"Value of novel agents and intensive therapy for patients with multiple myeloma","volume":"49","author":"Alexanian","year":"2014","journal-title":"Bone Marrow Transplantation"},{"key":"10.1111\/bjh.14570-BIB0003|bjh14570-cit-0003","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1200\/JCO.2011.36.5726","article-title":"Long-term analysis of the IFM 99 trials for myeloma: cytogenetic abnormalities [t(4;14), del(17p), 1q gains] play a major role in defining long-term survival","volume":"30","author":"Avet-Loiseau","year":"2012","journal-title":"Journal of Clinical Oncology"},{"key":"10.1111\/bjh.14570-BIB0004|bjh14570-cit-0004","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1182\/blood.V98.10.2992","article-title":"Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10","volume":"98","author":"Brown","year":"2001","journal-title":"Blood"},{"key":"10.1111\/bjh.14570-BIB0005|bjh14570-cit-0005","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1182\/blood-2004-04-1422","article-title":"HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells","volume":"105","author":"Carbone","year":"2005","journal-title":"Blood"},{"key":"10.1111\/bjh.14570-BIB0006|bjh14570-cit-0006","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1182\/blood.V96.1.355","article-title":"Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma","volume":"96","author":"Cavo","year":"2000","journal-title":"Blood"},{"key":"10.1111\/bjh.14570-BIB0007|bjh14570-cit-0007","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/imm.12082","article-title":"Differential expression of natural killer cell activating receptors in blood versus bone marrow in patients with monoclonal gammopathy","volume":"139","author":"Costello","year":"2013","journal-title":"Immunology"},{"key":"10.1111\/bjh.14570-BIB0008|bjh14570-cit-0008","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1046\/j.1365-2141.2002.03893.x","article-title":"Double-chimaerism after transplantation of two human leucocyte antigen mismatched, unrelated cord blood units","volume":"119","author":"De Lima","year":"2002","journal-title":"British Journal of Haematology"},{"key":"10.1111\/bjh.14570-BIB0009|bjh14570-cit-0009","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","article-title":"International uniform response criteria for multiple myeloma","volume":"20","author":"Durie","year":"2006","journal-title":"Leukemia"},{"key":"10.1111\/bjh.14570-BIB0010|bjh14570-cit-0010","doi-asserted-by":"publisher","first-page":"8444","DOI":"10.1158\/0008-5472.CAN-06-4230","article-title":"The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells","volume":"67","author":"El-Sherbiny","year":"2007","journal-title":"Cancer Research"},{"key":"10.1111\/bjh.14570-BIB0011|bjh14570-cit-0011","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/sj.leu.2404096","article-title":"Impaired activating receptor expression pattern in natural killer cells from patients with multiple myeloma","volume":"20","author":"Fauriat","year":"2006","journal-title":"Leukemia"},{"key":"10.1111\/bjh.14570-BIB0012|bjh14570-cit-0012","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/ejh.12481","article-title":"Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in\u00a0vitro","volume":"95","author":"Frassanito","year":"2015","journal-title":"European Journal of Haematology"},{"key":"10.1111\/bjh.14570-BIB0013|bjh14570-cit-0013","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1046\/j.1365-2141.2002.03879.x","article-title":"Anti-myeloma activity of natural killer lymphocytes","volume":"119","author":"Frohn","year":"2002","journal-title":"British Journal of Haematology"},{"key":"10.1111\/bjh.14570-BIB0014|bjh14570-cit-0014","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1093\/abbs\/gmu041","article-title":"Myeloma cells resistance to NK cell lysis mainly involves an HLA class I-dependent mechanism","volume":"46","author":"Gao","year":"2014","journal-title":"Acta Biochimica et Biophysica Sinica (Shanghai)"},{"key":"10.1111\/bjh.14570-BIB0015|bjh14570-cit-0015","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.3324\/haematol.2011.056747","article-title":"Highly activated and expanded natural killer cells for multiple myeloma immunotherapy","volume":"97","author":"Garg","year":"2012","journal-title":"Haematologica"},{"key":"10.1111\/bjh.14570-BIB0016|bjh14570-cit-0016","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/0161-5890(87)90057-5","article-title":"Regulation of human natural cytotoxicity by IgG-I. Characterization of the structural site on monomeric IgG responsible for inhibiting natural killer cell activity","volume":"24","author":"Gherman","year":"1987","journal-title":"Molecular Immunology"},{"key":"10.1111\/bjh.14570-BIB0017|bjh14570-cit-0017","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/bmt.2014.319","article-title":"Clinical impact of immunophenotypic remission after allogeneic hematopoietic cell transplantation in multiple myeloma","volume":"50","author":"Giaccone","year":"2015","journal-title":"Bone Marrow Transplantation"},{"key":"10.1111\/bjh.14570-BIB0018|bjh14570-cit-0018","first-page":"115","article-title":"NK cells and cancer immunoediting","volume":"395","author":"Guillerey","year":"2015","journal-title":"Current Topics in Microbiology and Immunology"},{"key":"10.1111\/bjh.14570-BIB0019|bjh14570-cit-0019","doi-asserted-by":"publisher","first-page":"5984","DOI":"10.1158\/1078-0432.CCR-05-0577","article-title":"Immunomodulatory drug CC-5013 or CC-4047 and rituximab enhance antitumor activity in a severe combined immunodeficient mouse lymphoma model","volume":"11","author":"Hernandez-Ilizaliturri","year":"2005","journal-title":"Clinical Cancer Research"},{"key":"10.1111\/bjh.14570-BIB0020|bjh14570-cit-0020","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.clml.2015.07.641","article-title":"Outcomes among high-risk and standard-risk multiple myeloma patients treated with high-dose chemotherapy and autologous hematopoietic stem-cell transplantation","volume":"15","author":"Kazmi","year":"2015","journal-title":"Clinical Lymphoma, Myeloma & Leukemia"},{"key":"10.1111\/bjh.14570-BIB0021|bjh14570-cit-0021","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1158\/1078-0432.CCR-13-3205","article-title":"Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity","volume":"20","author":"Kennedy-Nasser","year":"2014","journal-title":"Clinical Cancer Research"},{"key":"10.1111\/bjh.14570-BIB0022|bjh14570-cit-0022","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/leu.2008.291","article-title":"Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma","volume":"23","author":"Kyle","year":"2009","journal-title":"Leukemia"},{"key":"10.1111\/bjh.14570-BIB0023|bjh14570-cit-0023","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1182\/blood-2015-01-625004","article-title":"Lenalidomide augments actin remodeling and lowers NK-cell activation thresholds","volume":"126","author":"Lagrue","year":"2015","journal-title":"Blood"},{"key":"10.1111\/bjh.14570-BIB0024|bjh14570-cit-0024","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/leu.2015.356","article-title":"Management of relapsed multiple myeloma: recommendations of the international myeloma working group","volume":"30","author":"Laubach","year":"2016","journal-title":"Leukemia"},{"key":"10.1111\/bjh.14570-BIB0025|bjh14570-cit-0025","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nature16169","article-title":"Immune homeostasis enforced by co-localized effector and regulatory T cells","volume":"528","author":"Liu","year":"2015","journal-title":"Nature"},{"key":"10.1111\/bjh.14570-BIB0026|bjh14570-cit-0026","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1056\/NEJMoa1506348","article-title":"Targeting CD38 with daratumumab monotherapy in multiple myeloma","volume":"373","author":"Lokhorst","year":"2015","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/bjh.14570-BIB0027|bjh14570-cit-0027","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-020711-075005","article-title":"Controlling natural killer cell responses: integration of signals for activation and inhibition","volume":"31","author":"Long","year":"2013","journal-title":"Annual Review of Immunology"},{"key":"10.1111\/bjh.14570-BIB0028|bjh14570-cit-0028","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1056\/NEJMoa1505654","article-title":"Elotuzumab therapy for relapsed or refractory multiple myeloma","volume":"373","author":"Lonial","year":"2015","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/bjh.14570-BIB0029|bjh14570-cit-0029","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/cdd.2014.120","article-title":"Transmissible cytotoxicity of multiple myeloma cells by cord blood-derived NK cells is mediated by vesicle trafficking","volume":"22","author":"Martin-Antonio","year":"2015","journal-title":"Cell Death and Differentiation"},{"key":"10.1111\/bjh.14570-BIB0030|bjh14570-cit-0030","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1182\/blood-2004-07-2974","article-title":"Successful adoptive transfer and in\u00a0vivo expansion of human haploidentical NK cells in patients with cancer","volume":"105","author":"Miller","year":"2005","journal-title":"Blood"},{"key":"10.1111\/bjh.14570-BIB0031|bjh14570-cit-0031","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1182\/blood.V100.1.230","article-title":"Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6","volume":"100","author":"Ratta","year":"2002","journal-title":"Blood"},{"key":"10.1111\/bjh.14570-BIB0032|bjh14570-cit-0032","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.bbmt.2014.11.675","article-title":"Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Malignancies Working Party","volume":"21","author":"Robin","year":"2015","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1111\/bjh.14570-BIB0033|bjh14570-cit-0033","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1517\/14712598.2013.799130","article-title":"Immunologic microenvironment and personalized treatment in multiple myeloma","volume":"13","author":"Rossi","year":"2013","journal-title":"Expert Opinion on Biological Therapy"},{"key":"10.1111\/bjh.14570-BIB0034|bjh14570-cit-0034","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood.V94.1.333.413a31_333_339","article-title":"Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation","volume":"94","author":"Ruggeri","year":"1999","journal-title":"Blood"},{"key":"10.1111\/bjh.14570-BIB0035|bjh14570-cit-0035","doi-asserted-by":"publisher","first-page":"e64835","DOI":"10.1371\/journal.pone.0064835","article-title":"Hypoxia induced impairment of NK cell cytotoxicity against multiple myeloma can be overcome by IL-2 activation of the NK cells","volume":"8","author":"Sarkar","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1111\/bjh.14570-BIB0036|bjh14570-cit-0036","doi-asserted-by":"publisher","first-page":"e76781","DOI":"10.1371\/journal.pone.0076781","article-title":"Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity","volume":"8","author":"Shah","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1111\/bjh.14570-BIB0037|bjh14570-cit-0037","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/leu.2015.54","article-title":"Phase I\/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma","volume":"29","author":"Shah","year":"2015","journal-title":"Leukemia"},{"key":"10.1111\/bjh.14570-BIB0038|bjh14570-cit-0038","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1365-2141.2008.07340.x","article-title":"Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation","volume":"143","author":"Shi","year":"2008","journal-title":"British Journal of Haematology"},{"key":"10.1111\/bjh.14570-BIB0039|bjh14570-cit-0039","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/CJI.0000000000000059","article-title":"Ex vivo-expanded natural killer cells demonstrate robust proliferation in\u00a0vivo in high-risk relapsed multiple myeloma patients","volume":"38","author":"Szmania","year":"2015","journal-title":"Journal of Immunotherapy"},{"key":"10.1111\/bjh.14570-BIB0040|bjh14570-cit-0040","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1084\/jem.188.12.2375","article-title":"Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells","volume":"188","author":"Zamai","year":"1998","journal-title":"Journal of Experimental Medicine"},{"key":"10.1111\/bjh.14570-BIB0041|bjh14570-cit-0041","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s00262-008-0512-7","article-title":"Immunomodulatory drugs Revlimid (lenalidomide) and CC-4047 induce apoptosis of both hematological and solid tumor cells through NK cell activation","volume":"57","author":"Zhu","year":"2008","journal-title":"Cancer Immunology, Immunotherapy"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjh.14570","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjh.14570\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T07:55:28Z","timestamp":1625385328000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.14570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,14]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"URL":"https:\/\/doi.org\/10.1111\/bjh.14570","archive":["Portico"],"relation":{},"ISSN":["0007-1048"],"issn-type":[{"value":"0007-1048","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3,14]]}}}